Flexion Therapeutics (FLXN) Prices 9.23M Share Common Offering at $9.75/Sh

Flexion Therapeutics, Inc. (NASDAQ: FLXN) today announced the pricing of an underwritten public offering of 9,230,770 shares of its common stock at a price to the public of $9.75 per share. The gross proceeds from this offering are expected to be approximately $90.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Flexion. The offering is expected to close on or about May 26, 2020, subject to customary closing conditions. Flexion has also granted the underwriters a 30-day option to purchase up to 1,384,615 additional shares of its common stock at the public offering price, less the underwriting discounts and commissions.

Goldman Sachs & Co. LLC and Credit Suisse are acting as joint book-running managers for the offering. RBC Capital Markets is acting as senior manager and Raymond James and Needham & Company are acting as co-managers for the offering.

You May Also Be Interested In

• SpaceX prices IPO at $135 per share for June 12 Nasdaq debut
• Independence Realty Trust (IRT) files mixed shelf
• Healthcare Triangle raises $3.6 million through convertible note offering